Search - tctmd.com

Displaying 101 - 120 of 763

Sort: Relevancy | Date

Presentation TCT 2017

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Marie-Claude Morice

November 01, 2017

Presentation TCT 2017

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Renu Virmani

November 01, 2017

Presentation TCT 2017

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Saami K Yazdani

November 01, 2017

Presentation TCT 2017

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Luis F. Angel

November 01, 2017

Presentation TCT 2017

A Novel Micro-stent Technology Platform for BTK Interventions (Micromedical)

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Jihad A. Mustapha

November 01, 2017

News Conference News TCT 2017

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Shelley Wood

November 01, 2017

Presentation TCT 2017

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Costantino Del Giudice

November 01, 2017

Presentation TCT 2017

Statistical Comparison of the DANCE Trial 12-Month Outcomes of Adventitial Dexamethasone versus Comparator Drug-Coated Balloon Studies

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh

November 01, 2017

Presentation TCT 2017

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Piotr P. Buszman

November 01, 2017

Presentation TCT 2017

Pressure-controlled Intermittent Coronary Sinus Occlusion Reduces Infarct Size After Primary PCI: A Propensity-controlled Matched Study

Presenter: Dariusz Dudek, Cindy L. Grines, Azfar G. Zaman

November 01, 2017

Presentation TCT 2017

Cryotherapeutic Intervention in Primary PCI: The CHILL 1 FIH Study

Presenter: Dariusz Dudek, Cindy L. Grines, Maurice Buchbinder

November 01, 2017

Presentation TCT 2017

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Presenter: Dariusz Dudek, Cindy L. Grines, Liansheng Wang

November 01, 2017

Presentation TCT 2017

Novel Crossing System for CTO Recanalization

Presenter: Emmanouil S. Brilakis, Christopher E. Buller

November 01, 2017

Presentation TCT 2017

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Georgios Bouras

November 01, 2017

Presentation TCT 2017

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Presenter: Navin K. Kapur

November 01, 2017

Presentation TCT 2017

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Pieter R. Stella

November 01, 2017

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Arnold Seto

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Presentation TCT 2017

Featured Lecture: Complex PCI Intervention: Unresolved Technical Issues and Opportunities for Innovation

Presenter: Emmanouil S. Brilakis, Christopher E. Buller

November 01, 2017

Advertisement

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

A Novel Micro-stent Technology Platform for BTK Interventions (Micromedical)

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Statistical Comparison of the DANCE Trial 12-Month Outcomes of Adventitial Dexamethasone versus Comparator Drug-Coated Balloon Studies

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Pressure-controlled Intermittent Coronary Sinus Occlusion Reduces Infarct Size After Primary PCI: A Propensity-controlled Matched Study

Cryotherapeutic Intervention in Primary PCI: The CHILL 1 FIH Study

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Novel Crossing System for CTO Recanalization

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Featured Lecture: Complex PCI Intervention: Unresolved Technical Issues and Opportunities for Innovation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content